Birtamimab: a new amyloidosis treatment? No … ← Birtamimab: a new amyloidosis treatment? Cell-of-Origin Effect of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma: No Ordinary Subgroup Analysis →